← Open Payments lookup

AVERY MARZULLA-DULFER: Open Payments

NPI 1639453988 · NEW HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$370 in 7 payments from 7 companies in 2025. Trend: 2023 $262 · 2024 $78 · 2025 $370

Food & beverage: $370
CompanyPaymentsAmount
Eisai Inc.1$125
GENZYME CORPORATION1$125
ARRAY BIOPHARMA INC1$30
Daiichi Sankyo Inc.1$29
Novartis Pharmaceuticals Corporation1$22
Iovance Biotherapeutics, Inc.1$19
ABBVIE INC.1$19

Products named: Lenvima, SARCLISA, LORBRENA, DATROWAY, SCEMBLIX, Amtagvi, EMRELIS.

Industry payments across CT — which companies pay providers there.